In last trading session, Aptose Biosciences Inc (NASDAQ:APTO) saw 1.04 million shares changing hands with its beta currently measuring 1.06. Company’s recent per share price level of $0.18 trading at $0.0 or 0.56% at ring of the bell on the day assigns it a market valuation of $3.49M. That closing price of APTO’s stock is at a discount of -1516.67% from its 52-week high price of $2.91 and is indicating a premium of 27.78% from its 52-week low price of $0.13. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.79 million shares which gives us an average trading volume of 765.53K if we extend that period to 3-months.
For Aptose Biosciences Inc (APTO), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.35 in the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Aptose Biosciences Inc (NASDAQ:APTO) trade information
Upright in the green during last session for gaining 0.56%, in the last five days APTO remained trading in the red while hitting it’s week-highest on Thursday, 11/21/24 when the stock touched $0.18 price level, adding 40.36% to its value on the day. Aptose Biosciences Inc’s shares saw a change of -92.95% in year-to-date performance and have moved -34.46% in past 5-day. Aptose Biosciences Inc (NASDAQ:APTO) showed a performance of -54.04% in past 30-days. Number of shares sold short was 0.12 million shares which calculate 1.61 days to cover the short interests.
Aptose Biosciences Inc (APTO) estimates and forecasts
Statistics highlight that Aptose Biosciences Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -84.57% of value to its shares in past 6 months, showing an annual growth rate of 76.39% while that of industry is 17.70. Apart from that, the company came raising its revenue forecast for fiscal year 2024.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 10.18% during past 5 years.
Aptose Biosciences Inc (NASDAQ:APTO)’s Major holders
Insiders are in possession of 16.39% of company’s total shares while institution are holding 16.68 percent of that, with stock having share float percentage of 19.96%. Investors also watch the number of corporate investors in a company very closely, which is 16.68% institutions for Aptose Biosciences Inc that are currently holding shares of the company. DOHENY ASSET MANAGEMENT /CA is the top institutional holder at APTO for having 50550.0 shares of worth $0.32 million. And as of 2024-06-30, it was holding 0.3849 of the company’s outstanding shares.
The second largest institutional holder is CALDWELL SUTTER CAPITAL, INC., which was holding about 92.0 shares on 2024-06-30. The number of shares represents firm’s hold over 0.0007 of outstanding shares, having a total worth of $70.0.
On the other hand, Fidelity NASDAQ Composite Index Fund and DFA Investment Dimensions-Canadian Small Company Series are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 2.16 shares of worth $386.0 or 0.01% of the total outstanding shares. The later fund manager was in possession of 767.0 shares on Jul 31, 2024 , making its stake of worth around $137.0 in the company or a holder of 0.00% of company’s stock.
